Scipio bioscience

📍 Paris, France🗓 Founded 2017👥 42 employees💰 Last funded Apr 2022
Biotechnology Research🌐 scipio.bio
Website LinkedIn
Scipio Bioscience, a Paris-based biotechnology company, provides novel sample preparation solutions for single-cell studies in the form of easy-to-use benchtop kits and intuitive, cloud-based software. Scipio Bioscience exploits a proprietary technology for barcoding for preparation of samples for single-cell profiling. The initial target of Scipio Bioscience is to provide sample preparation for single-cell transcriptomics freed of the substantial investment and running costs of existing technologies, while attaining the flexibility and scalability required in state-of-the-art research. The blooming applications in single-cell transcriptomics have revealed the importance of characterizing the diversity of cell profiles in normal tissues and cancerous tumors. For optimal results, numbers of cells in the range of thousands must be analyzed simultaneously by RNA-sequencing procedures. The costs and constraints of available methods for sample preparation have hampered widespread adoption of this approach. Scipio Bioscience overcomes these obstacles by providing a test-tube solution readily accessible to laboratories in all fields of biological research. The first outcome of this technology was the commercial release of the Asteria™ Single-cell RNA-seq Kit and its companion data analysis software Cytonaut™ in May 2022. Able to analyze 10,000 input cells in a single-tube, the kit bypasses the use of microfluidics or plate in favor of a simple, accessible protocol that is easier on cells and enables a stable stopping point 2 hours in. The resulting sequencing data can be analyzed with Cytonaut™, a cloud-based software that covers the entire 3’ scRNA-seq data analysis chain and emphasizes on the ease-of-use for biologists and bioinformaticians alike. Scipio bioscience is housed in the Paris Santé Cochin incubator, located in the celebrated Parisian Cochin Hospital.
5
Total investors
2
Early stage
3
Mid stage
0
Late stage
2017
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Netherlands
2
France
2
Germany
1
Investor activity2017–2022 · investors recorded per year
201722020220221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Scipio bioscience?
Scipio bioscience has 5 investors on record on gritt.io, including 2 early-stage backers, 3 mid-stage.
When did Scipio bioscience last raise funding?
The most recent investment in Scipio bioscience recorded on gritt.io was in April 2022.
When was Scipio bioscience founded?
Scipio bioscience was founded in 2017.
What industry is Scipio bioscience in?
Scipio bioscience operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Scipio bioscience based?
Scipio bioscience is headquartered in Paris, France.